{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T03:23:25Z","timestamp":1776223405891,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10120-018-0831-0","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T11:40:01Z","timestamp":1525434001000},"page":"1031-1040","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Comparative effectiveness of adjuvant treatments for resected gastric cancer: a network meta-analysis"],"prefix":"10.1007","volume":"21","author":[{"given":"Zhaolun","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqiong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0254-5843","authenticated-orcid":false,"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"issue":"5","key":"831_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"Jacques Ferlay","year":"2014","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5).","journal-title":"International Journal of Cancer"},{"issue":"suppl 5","key":"831_CR2","doi-asserted-by":"publisher","first-page":"v38","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38\u2013v49. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdw350\n                    \n                   (Epub 2016\/09\/25)","journal-title":"Ann Oncol"},{"issue":"5","key":"831_CR3","first-page":"80816","volume":"240","author":"MI Dangelica","year":"2004","unstructured":"Dangelica MI, Gonen M, Brennan MF, Turnbull AD, Bains MS, Karpeh MS. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240(5):808\u201316.","journal-title":"Ann Surg"},{"issue":"17","key":"831_CR4","doi-asserted-by":"publisher","first-page":"172937","DOI":"10.1001\/jama.2010.534","volume":"303","author":"X Paoletti","year":"2010","unstructured":"Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, Pignon JP, et al. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. Jama. 2010;303(17):1729\u201337. \n                    https:\/\/doi.org\/10.1001\/jama.2010.534\n                    \n                  . (Epub 2010\/05\/06)","journal-title":"Jama"},{"key":"831_CR5","doi-asserted-by":"publisher","unstructured":"Diaz-Nieto R, Orti-Rodriguez R, Winslet M. Post-surgical chemotherapy versus surgery alone for resectable gastric cancer. The Cochrane database of systematic reviews. 2013;9:CD008415. \n                    https:\/\/doi.org\/10.1002\/14651858.CD008415.pub2\n                    \n                   (Epub 2013\/09\/04)","DOI":"10.1002\/14651858.CD008415.pub2"},{"issue":"1","key":"831_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12957-016-0957-7","volume":"14","author":"ML Zhou","year":"2016","unstructured":"Zhou ML, Kang M, Li GC, Guo XM, Zhang Z. Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis. World J Surg Oncol. 2016;14(1):209. \n                    https:\/\/doi.org\/10.1186\/s12957-016-0957-7\n                    \n                   (Epub 2016\/08\/10)","journal-title":"World J Surg Oncol"},{"key":"831_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/s1470","volume":"15","author":"SH Noh","year":"2014","unstructured":"Noh SH, Park SR, Yang HK, Chung HC, Chung IJ, Kim SW, et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC]: 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol. 2014;15(12):1389\u201396. \n                    https:\/\/doi.org\/10.1016\/s1470\n                    \n                   (Epub 2014\/12\/03)","journal-title":"Lancet Oncol"},{"issue":"33","key":"831_CR8","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/jco.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387\u201393. \n                    https:\/\/doi.org\/10.1200\/jco.2011.36.5908\n                    \n                   (Epub 2011\/10\/20)","journal-title":"J Clin Oncol"},{"issue":"6","key":"831_CR9","doi-asserted-by":"publisher","first-page":"38898","DOI":"10.1093\/jnci\/djn054","volume":"100","author":"F Costanzo Di","year":"2008","unstructured":"Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, et al. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst. 2008;100(6):388\u201398. \n                    https:\/\/doi.org\/10.1093\/jnci\/djn054\n                    \n                   (Epub 2008\/03\/13)","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"831_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/bjs.5996","volume":"94","author":"T Nakajima","year":"2007","unstructured":"Nakajima T, Kinoshita T, Nashimoto A, Sairenji M, Yamaguchi T, Sakamoto J, et al. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg. 2007;94(12):1468\u201376. \n                    https:\/\/doi.org\/10.1002\/bjs.5996\n                    \n                   (Epub 2007\/10\/20)","journal-title":"Br J Surg"},{"issue":"19","key":"831_CR11","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1200\/jco.2011.36.7136","volume":"30","author":"SR Smalley","year":"2012","unstructured":"Smalley SR, Benedetti JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30(19):2327\u201333. \n                    https:\/\/doi.org\/10.1200\/jco.2011.36.7136\n                    \n                   (Epub 2012\/05\/16)","journal-title":"J Clin Oncol"},{"issue":"28","key":"831_CR12","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.1200\/jco.2014.58.3930","volume":"33","author":"SH Park","year":"2015","unstructured":"Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM, et al. Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol. 2015;33(28):3130\u20136. \n                    https:\/\/doi.org\/10.1200\/jco.2014.58.3930\n                    \n                   (Epub 2015\/01\/07)","journal-title":"J Clin Oncol"},{"issue":"10","key":"831_CR13","first-page":"1286312","volume":"14","author":"JA Ajani","year":"2016","unstructured":"Ajani JA, Damico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology. J Natl Comprehensive Cancer Netw. 2016;14(10):1286\u2013312.","journal-title":"J Natl Comprehensive Cancer Netw"},{"key":"831_CR14","doi-asserted-by":"publisher","unstructured":"Japanese gastric cancer treatment guidelines 2014 (ver. 4] Gastric Cancer. 2016;20(1):1\u201319. \n                    https:\/\/doi.org\/10.1007\/s10120-016-0622-4\n                    \n                  .","DOI":"10.1007\/s10120-016-0622-4"},{"issue":"2","key":"831_CR15","doi-asserted-by":"publisher","first-page":"33240","DOI":"10.1007\/s10120-016-0606-4","volume":"20","author":"N Fuse","year":"2017","unstructured":"Fuse N, Bando H, Chin K, Ito S, Yoshikawa T, Tsuburaya A, et al. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Gastric Cancer. 2017;20(2):332\u201340.","journal-title":"Gastric Cancer"},{"issue":"1","key":"831_CR16","doi-asserted-by":"publisher","first-page":"17581","DOI":"10.1007\/s10120-015-0581-1","volume":"20","author":"K Shitara","year":"2017","unstructured":"Shitara K, Chin K, Yoshikawa T, Katai H, Terashima M, Ito S, et al. Phase II study of adjuvant chemotherapy of S-1 plus oxaliplatin for patients with stage III gastric cancer after D2 gastrectomy. Gastric Cancer. 2017;20(1):175\u201381. \n                    https:\/\/doi.org\/10.1007\/s10120-015-0581-1\n                    \n                   (Epub 2015\/12\/03)","journal-title":"Gastric Cancer"},{"issue":"Supplement 1","key":"831_CR17","doi-asserted-by":"publisher","first-page":"i28","DOI":"10.1093\/jjco\/hyq124","volume":"40","author":"M. Sasako","year":"2010","unstructured":"Sasako M, Inoue M, Lin J, Khor C, Yang H, Ohtsu A. Gastric cancer working group report. Jpn J Clin Oncol. 2010;40.","journal-title":"Japanese Journal of Clinical Oncology"},{"issue":"16","key":"831_CR18","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/sim.1201","volume":"21","author":"T Lumley","year":"2002","unstructured":"Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002;21(16):2313\u201324.","journal-title":"Stat Med"},{"issue":"4","key":"831_CR19","doi-asserted-by":"publisher","first-page":"31224","DOI":"10.1002\/jrsm.1058","volume":"3","author":"G Rucker","year":"2012","unstructured":"Rucker G. Network meta-analysis, electrical networks and graph theory. Res Synthesis Methods. 2012;3(4):312\u201324.","journal-title":"Res Synthesis Methods"},{"issue":"7387","key":"831_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/bmj.326.7387.472","volume":"326","author":"F Song","year":"2003","unstructured":"Song F, Altman DG, Glenny A, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326(7387):472","journal-title":"BMJ"},{"issue":"5","key":"831_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0272989X12458724","volume":"33","author":"S Dias","year":"2013","unstructured":"Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making. 2013;33(5):607\u201317. \n                    https:\/\/doi.org\/10.1177\/0272989X12458724\n                    \n                  . (Epub 2012\/10\/30)","journal-title":"Med Decis Making"},{"issue":"2","key":"831_CR22","first-page":"S38","volume":"5","author":"HJP Gs","year":"2014","unstructured":"Gs HJP. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011]. Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie Pharmakologie. 2014;5(2):S38.","journal-title":"Naunyn-Schmiedebergs Archiv f\u00fcr experimentelle Pathologie Pharmakologie"},{"key":"831_CR23","unstructured":"Greene FL. AJCC Cancer Staging Manual (6th Edition)."},{"issue":"oct18 2","key":"831_CR24","doi-asserted-by":"publisher","first-page":"d5928-d","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj. 2011;343(oct18 2):d5928-d.","journal-title":"Bmj"},{"issue":"10]","key":"831_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10]):e1\u201334. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2009.06.006","journal-title":"J Clin Epidemiol"},{"key":"831_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. \n                    https:\/\/doi.org\/10.1186\/1745-6215-8-16","journal-title":"Trials"},{"key":"831_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/sim.3767","volume":"29","author":"S Dias","year":"2010","unstructured":"Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932\u201344.","journal-title":"Stat Med"},{"issue":"2","key":"831_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","volume":"64","author":"G Salanti","year":"2011","unstructured":"Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163\u201371. \n                    https:\/\/doi.org\/10.1016\/j.jclinepi.2010.03.016\n                    \n                   (Epub 2010\/08\/07)","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"831_CR29","doi-asserted-by":"publisher","first-page":"88693","DOI":"10.1016\/s1470-2045(14)70025-7","volume":"15","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, et al. Sequential paclitaxel followed by tegafur and uracil (UFT] or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a\/b gastric cancer (SAMIT]: a phase 3 factorial randomised controlled trial. Lancet Oncol. 2014;15(8):886\u201393. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(14)70025-7\n                    \n                   (Epub 2014\/06\/24)","journal-title":"Lancet Oncol"},{"issue":"8","key":"831_CR30","doi-asserted-by":"publisher","first-page":"601-7","DOI":"10.1093\/jnci\/djk131","volume":"99","author":"S Cascinu","year":"2007","unstructured":"Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst. 2007;99(8):601-7. \n                    https:\/\/doi.org\/10.1093\/jnci\/djk131\n                    \n                   (Epub 2007\/04\/19)","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"831_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4143\/crt.2004.36.2.140","volume":"36","author":"JJ Lee","year":"2004","unstructured":"Lee JJ, Kim SY, Shin IS, Cho KS, Joo HZ, Yoon C, et al. Randomized phase III trial of cisplatin, epirubicin, leucovorin, 5-fluorouracil (PELF] combination versus 5-fluorouracil alone as adjuvant chemotherapy in curative resected stage III gastric cancer. Cancer Res Treatment. 2004;36(2):140\u20135. \n                    https:\/\/doi.org\/10.4143\/crt.2004.36.2.140\n                    \n                   (Epub 2004\/04\/01)","journal-title":"Cancer Res Treatment"},{"issue":"3","key":"831_CR32","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1016\/j.radonc.2012.08.024","volume":"104","author":"WG Zhu","year":"2012","unstructured":"Zhu WG, Xua DF, Pu J, Zong CD, Li T, Tao GZ, et al. A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection. Radiother Oncol J Eur Soc Therapeutic Radiol Oncol. 2012;104(3):361\u20136. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2012.08.024\n                    \n                   (Epub 2012\/09\/19)","journal-title":"Radiother Oncol J Eur Soc Therapeutic Radiol Oncol"},{"issue":"9175","key":"831_CR33","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1016\/S0140-6736%2899%2901048-X","volume":"354","author":"T Nakajima","year":"1999","unstructured":"Nakajima T, Nashimoto A, Kitamura M, Kito T, Iwanaga T, Okabayashi K, et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomised trial. Lancet (London England). 1999;354(9175):273\u20137. \n                    https:\/\/doi.org\/10.1016\/S0140-6736%2899%2901048-X","journal-title":"Lancet (London England)"},{"issue":"4","key":"831_CR34","doi-asserted-by":"publisher","first-page":"27885","DOI":"10.1111\/j.1743-7563.2010.01331.x","volume":"6","author":"HC Kwon","year":"2010","unstructured":"Kwon HC, Kim MC, Kim KH, Jang JS, Oh SY, Kim SH, et al. Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection. Asia Pac J Clin Oncol. 2010;6(4):278\u201385. \n                    https:\/\/doi.org\/10.1111\/j.1743-7563.2010.01331.x\n                    \n                   (Epub 2010\/12\/01)","journal-title":"Asia Pac J Clin Oncol"},{"issue":"10","key":"831_CR35","doi-asserted-by":"publisher","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","volume":"8","author":"Anna Chaimani","year":"2013","unstructured":"Chaimani A, Higgins JPT, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. Plos One. 2013;8(10).","journal-title":"PLoS ONE"},{"key":"831_CR36","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002. \n                    https:\/\/doi.org\/10.1136\/bmj.d4002\n                    \n                   (Epub 2011\/07\/26)","journal-title":"BMJ"},{"issue":"12","key":"831_CR37","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1016\/s1470-2045(13)70436-4","volume":"14","author":"L Shen","year":"2013","unstructured":"Shen L, Shan Y-S, Hu H-M, Price TJ, Sirohi B, Yeh K-H, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14(12):e535\u2013e47. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(13)70436-4\n                    \n                  .","journal-title":"Lancet Oncol"},{"issue":"2","key":"831_CR38","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1007\/s10120-013-0264-8","volume":"17","author":"D Takahari","year":"2014","unstructured":"Takahari D, Hamaguchi T, Yoshimura K, Katai H, Ito S, Fuse N, et al. Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. Gastric Cancer. 2014;17(2):383\u20136. \n                    https:\/\/doi.org\/10.1007\/s10120-013-0264-8\n                    \n                   (Epub 2013\/05\/31)","journal-title":"Gastric Cancer"},{"issue":"2","key":"831_CR39","doi-asserted-by":"publisher","first-page":"34853","DOI":"10.1007\/s10120-013-0273-7","volume":"17","author":"K Fujitani","year":"2014","unstructured":"Fujitani K, Tamura S, Kimura Y, Tsuji T, Matsuyama J, Iijima S, et al. Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy. Gastric Cancer. 2014;17(2):348\u201353. \n                    https:\/\/doi.org\/10.1007\/s10120-013-0273-7\n                    \n                   (Epub 2013\/06\/06)","journal-title":"Gastric Cancer"},{"key":"831_CR40","doi-asserted-by":"crossref","unstructured":"Nakamura Y, Yamanaka T, Chin K, Cho H, Katai H, Terashima M, et al. Three-year outcomes of two phase II studies of adjuvant chemotherapy with S-1 plus oxaliplatin or capecitabine plus oxaliplatin in patients with stage III gastric cancer after D2 gastrectomy. American Society of Clinical Oncology; 2018.","DOI":"10.1200\/JCO.2018.36.4_suppl.94"},{"issue":"6","key":"831_CR41","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010;17(6):1471\u20134.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"831_CR42","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00280-010-1256-6","volume":"65","author":"A Bamias","year":"2010","unstructured":"Bamias A, Karina M, Papakostas P, Kostopoulos I, Bobos M, Vourli G, et al. A randomized phase III study of adjuvant platinum\/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. Cancer Chemother Pharmacol. 2010;65(6):1009\u201321. \n                    https:\/\/doi.org\/10.1007\/s00280-010-1256-6\n                    \n                   (Epub 2010\/02\/05)","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-018-0831-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-018-0831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-018-0831-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T20:04:41Z","timestamp":1556913881000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-018-0831-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s10120-018-0831-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}